US hospitals face severe ventilator drugs shortage
Coronavirus outbreak has caused a 51% increase in demand for sedatives and anaesthetics in March
This article discusses guidelines specifically for anesthesiologists dealing with ophthalmic surgeries with suspected or confirmed COVID-19 patients. Anesthesiologists always work in the proximity of the patient's face while performing either ocular regional anesthesia or while managing the airway in the process of intubation/extubation. Within these guidelines, the emphasis is provided on thorough preoperative screening to identify COVID-19 patients and to prevent the exposure of healthcare staff by following standard personal protective equipment (PPE) precautions.
In this report, we have summarized the guidelines necessary for airway management of suspected/confirmed COVID-19 patient. Since the COVID-19 outbreak is up to date existed, therefore this report is considered as interim guidelines for airway management of the suspected/confirmed patients. The guidelines will be revisited and modified in the future, if necessary.
Since its emergence in December 2019, the outbreak of novel coronavirus disease 2019 (COVID-19) has infected over 2 626 321 people globally.1 COVID-19 is associated with wide variability in disease severity, ranging from asymptomatic to severe critical presentations. In initial data from China, mild thrombocytopenia was found to occur in just over a third of non-pregnant patients admitted to hospital with COVID-19. A more recent meta-analysis found that thrombocytopenia is associated with a three-fold greater risk of severe COVID-19.
THE CORONAVIRUS DISEASE 2019 (COVID-19) outbreak that spread from Wuhan, China, in December 2019 became a global pandemic within about 2 months, causing more than 330,000 deaths worldwide so far (at the time of writing).1 This has forced hospitals in the most affected countries and regions around the world to rearrange their activity, creating new spaces and pathways while reducing nonurgent admissions and health services.2 Although only a minority of patients infected with the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) develop symptoms severe enough to require intensive care unit (ICU) admission,3 th...
IN DECEMBER 2019 a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (coronavirus-2019 [COVID-19]) was reported in Wuhan, China, and it rapidly spread across the world.1 On February 21, a 78-year-old man became the first person in Europe to die as a result of COVID-19 in a community hospital in Veneto, a region of about 5,000,000 people located in northeast Italy. Since then, SARS-CoV-2 has become a relentless epidemic in Italy, with a dramatic increase in the number of patients showing COVID-19 –related acute respiratory failure and hypoxemia.
We describe our center's methodology for pediatric patient risk stratification to facilitate responsible use of endoscopic resources during this crisis. We also describe our recommendations for use of personal protective equipment by endoscopists, with the goal of ensuring the safety of ourselves, our anesthesiology and endoscopy staff, and our patients.
The severe acute respiratory syndrome coronavirus-2 –related disease, coronavirus-2019 (COVID-19), mainly is characterized by respiratory manifestations, with approximately 15% to 30% of patients developing acute respiratory distress syndrome (ARDS).1 The World Health Organization guidelines recommend to proceed to venovenous extracorporeal membran e oxygenation (ECMO) for eligible patients with COVID-19–related ARDS only in centers with “sufficient case volume to ensure clinical expertise.”2 The Amiens ECMO center received many calls from several hospitals in the region about refractory ARDS second...
Baljit Singh, Rakesh Garg, S S C Chakra Rao, Syed M Ahmed, JV Divatia, TV Ramakrishnan, Lalit Mehdiratta, Muralidhar Joshi, Naveen Malhotra, Sukhminder Jit Singh BajwaIndian Journal of Anaesthesia 2020 64(14):91-96 Management of the recent outbreak of the novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) remains challenging. The challenges are not only limited to its preventive strategies, but also extend to curative treatment, and are amplified during the management of critically ill patients with COVID-19. Older persons with comorbidities like diabetes mellitu...
This article addresses specific concerns for the anesthetic management of the pediatric population with COVID-19. PMID: 32438527 [PubMed - as supplied by publisher]